1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Phosphodiesterase 5 and its inhibitors with ischemic heart disease : a Mendelian randomization analysis and a real-world study
2024) In European heart journal. Cardiovascular pharmacotherapy(
- Contribution to journal › Article
-
Mark
PDE5 inhibition mitigates heart failure in hyperlipidemia
(
- Contribution to journal › Article
- 2023
-
Mark
Association of genetically-predicted lipid traits and lipid-modifying targets with heart failure
(
- Contribution to journal › Article
- 2022
-
Mark
Use of dipyridamole is associated with lower risk of lymphoid neoplasms : a propensity score-matched cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Reactome Pathway Analysis of Venous Thromboembolism, Peripheral Artery Disease, Stroke, and Coronary Artery Disease
(
- Contribution to journal › Letter
-
Mark
Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study
(
- Contribution to journal › Article
-
Mark
Beta-blockers use and risk of breast cancer in women with hypertension
2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(5). p.965-973(
- Contribution to journal › Article
- 2020
-
Mark
Mortality risks associated with sibling heart failure
(
- Contribution to journal › Article
- 2018
-
Mark
Clinical and epidemiological features of Heart-Hand Syndrome : A hospital-based study in China
(
- Contribution to journal › Article
- 2017
-
Mark
Body Height and Incident Risk of Venous Thromboembolism : A Cosibling Design
(
- Contribution to journal › Article